7 min. Read

AstraZeneca’s digital health strategy. Pear and Cognoa studies.

Issue 046.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 56 percent open rate. Here's what's happening this week:

  • Working toward the next long-form report, which will be focused on musculoskeletal (MSK) digital therapeutics companies. (Like many, I was surprised by Hinge Health's $90 million raise earlier this year.) Send tips, rumors, and requests my way if this one is of interest.
  • Livongo abandoned its trademark for "Cuff to Cloud", which was its brand for the voice-enabled health nudging feature it has developed with Amazon's developer tools. Despite the trademark sunsetting, Livongo tells me the voice-enabled feature is still very much a part of its hypertension program.
  • Health Advances' Partner Andrew Matzkin has a worthwhile column outlining the ways the COVID--19 pandemic is likely to shape the future of

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Cigna bought MDLIVE for $2B cash in 2021
6 min. Read
Pear bought Pear. New HCPCS attempts. Trials
8 min. Read
Pear sold for $6M. Woebot pauses PDTs. Swing-FDA
6 min. Read
Quest bought Pack Health for $123M cash. Trials
6 min. Read
New digital health CPT code hopefuls. Trials
5 min. Read
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
4 min. Read
Pricing Database update: 60+ digital health prices.
3 min. Read
E&O readers analyze fate of Pear, PDTs. FDA-AI
8 min. Read
Seven secret health tech funding deals
3 min. Read
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
10 min. Read
  • First
  • Previous
  • 1 of 32
  • Next
  • Last